120 related articles for article (PubMed ID: 7526593)
21. Effect of hydrogen sulfide on cyclic AMP production in isolated bovine and porcine neural retinae.
Njie-Mbye YF; Bongmba OY; Onyema CC; Chitnis A; Kulkarni M; Opere CA; LeDay AM; Ohia SE
Neurochem Res; 2010 Mar; 35(3):487-94. PubMed ID: 19898983
[TBL] [Abstract][Full Text] [Related]
22. Neuropeptide Y receptor-effector coupling mechanisms in cultured vascular smooth muscle cells.
Reynolds EE; Yokota S
Biochem Biophys Res Commun; 1988 Mar; 151(2):919-25. PubMed ID: 2831905
[TBL] [Abstract][Full Text] [Related]
23. Effects of GTP, forskolin, sodium fluoride, serotonin, dopamine, and carbachol on adenylate cyclase in Teleost retina.
Osborne NN
Neurochem Res; 1990 May; 15(5):523-8. PubMed ID: 1695328
[TBL] [Abstract][Full Text] [Related]
24. Direct effects of cutaneous neuropeptides on adenylyl cyclase activity and proliferation in a keratinocyte cell line: stimulation of cyclic AMP formation by CGRP and VIP/PHM, and inhibition by NPY through G protein-coupled receptors.
Takahashi K; Nakanishi S; Imamura S
J Invest Dermatol; 1993 Nov; 101(5):646-51. PubMed ID: 8228323
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of noradrenaline release by neuropeptide Y in mouse atria does not involve inhibition of adenylate cyclase or a pertussis toxin-susceptible G protein.
Foucart S; Majewski H
Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6):658-65. PubMed ID: 2482450
[TBL] [Abstract][Full Text] [Related]
26. Heterologous sensitization of adenylate cyclase is protein kinase A-dependent in Cath.a differentiated (CAD)-D2L cells.
Johnston CA; Beazely MA; Vancura AF; Wang JK; Watts VJ
J Neurochem; 2002 Sep; 82(5):1087-96. PubMed ID: 12358756
[TBL] [Abstract][Full Text] [Related]
27. Neuropeptide Y-induced intracellular Ca2+ increases in vascular smooth muscle cells.
Mihara S; Shigeri Y; Fujimoto M
FEBS Lett; 1989 Dec; 259(1):79-82. PubMed ID: 2480920
[TBL] [Abstract][Full Text] [Related]
28. A novel cyclic analog of neuropeptide Y specific for the Y2 receptor.
Beck-Sickinger AG; Grouzmann E; Hoffmann E; Gaida W; van Meir EG; Waeber B; Jung G
Eur J Biochem; 1992 Jun; 206(3):957-64. PubMed ID: 1318842
[TBL] [Abstract][Full Text] [Related]
29. Coexpression of Y1, Y2, and Y4 receptors in smooth muscle coupled to distinct signaling pathways.
Misra S; Murthy KS; Zhou H; Grider JR
J Pharmacol Exp Ther; 2004 Dec; 311(3):1154-62. PubMed ID: 15308651
[TBL] [Abstract][Full Text] [Related]
30. Relaxant effect of forskolin in rabbit detrusor smooth muscle: role of cyclic AMP.
Morita T; Wheeler MA; Weiss RM
J Urol; 1986 Jun; 135(6):1293-5. PubMed ID: 3012124
[TBL] [Abstract][Full Text] [Related]
31. Species differences in the effects of substance P on inositol trisphosphate accumulation and cyclic AMP formation, and on contraction in isolated iris sphincter of the mammalian eye: differences in receptor density.
Tachado SD; Akhtar RA; Yousufzai SY; Abdel-Latif AA
Exp Eye Res; 1991 Dec; 53(6):729-39. PubMed ID: 1723688
[TBL] [Abstract][Full Text] [Related]
32. Histamine-mediated regulation of cAMP levels and inositol phosphate metabolism in isolated rabbit retina.
Nowak JZ; Sek B; Szkiel B
Agents Actions; 1989 Apr; 27(1-2):131-4. PubMed ID: 2546406
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of interaction between neuropeptide Y and angiotensin II in the rabbit femoral artery.
Cressier F; Criscione L; Hofbauer KG
Eur J Pharmacol; 1995 Jan; 272(1):57-65. PubMed ID: 7713150
[TBL] [Abstract][Full Text] [Related]
34. Effects of intracerebroventricular D-myo-inositol-1,2,6-trisphosphate (PP56), a proposed neuropeptide Y (NPY) antagonist, on locomotor activity, food intake, central effects of NPY and NPY-receptor binding.
Heilig M; Edvinsson L; Wahlestedt C
Eur J Pharmacol; 1991 Dec; 209(1-2):27-32. PubMed ID: 1667639
[TBL] [Abstract][Full Text] [Related]
35. Neuropeptide Y inhibition of vasoactive intestinal polypeptide-stimulated ion transport in the rabbit distal colon.
Flint JS; Ballantyne GH; Goldenring JR; Fielding LP; Modlin IM
Arch Surg; 1990 Dec; 125(12):1561-3. PubMed ID: 2173897
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of NPY on isoprenaline-induced osteoclastogenesis in mouse bone marrow cells.
Amano S; Arai M; Goto S; Togari A
Biochim Biophys Acta; 2007 Jun; 1770(6):966-73. PubMed ID: 17383824
[TBL] [Abstract][Full Text] [Related]
37. Neuropeptide Y expression and regulation in a differentiated rat insulin-secreting cell line.
Waeber G; Thompson N; Waeber B; Brunner HR; Nicod P; Grouzmann E
Endocrinology; 1993 Sep; 133(3):1061-7. PubMed ID: 8396008
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of cyclic AMP accumulation mediated by 5-HT after chronic amitriptyline treatment in NG 108-15 cells.
Shimizu M; Nishida A; Fukuda H; Saito H; Yamawaki S
Br J Pharmacol; 1995 Mar; 114(6):1282-8. PubMed ID: 7620719
[TBL] [Abstract][Full Text] [Related]
39. Dopaminergic mechanisms in the teleost retina. II. Factors affecting the accumulation of cyclic AMP in pieces of intact carp retina.
Dowling JE; Watling KJ
J Neurochem; 1981 Feb; 36(2):569-79. PubMed ID: 6162007
[TBL] [Abstract][Full Text] [Related]
40. Neurotransmitter-mediated inhibition of post-mortem human brain adenylyl cyclase.
Garlind A; Fowler CJ; Alafuzoff I; Winblad B; Cowburn RF
J Neural Transm Gen Sect; 1992; 87(2):113-24. PubMed ID: 1348419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
